Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Cboe CA - Delayed Quote CAD

Filament Health Corp. (FH.NE)

0.0250
-0.0100
(-28.57%)
At close: April 23 at 10:01:04 AM EDT
Currency in CAD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
616.6780
616.6780
2,130.9740
364.5000
--
Cost of Revenue
--
--
--
--
913.6470
Gross Profit
--
--
--
364.5000
-913.6470
Operating Expense
4,285.9540
4,285.9540
7,050.6180
5,879.0480
6,355.2760
Operating Income
-3,669.2760
-3,669.2760
-4,919.6440
-5,514.5480
-7,268.9230
Net Non Operating Interest Income Expense
-238.8120
-238.8120
-374.5670
-184.6700
-40.0830
Other Income Expense
-1,062.1840
-1,062.1840
-27.8210
-10,837.7850
-1,982.3490
Pretax Income
-4,970.2720
-4,970.2720
-5,322.0320
-16,537.0030
-9,291.3550
Tax Provision
--
--
--
-70.5380
-37.7480
Net Income Common Stockholders
-4,970.2720
-4,970.2720
-5,322.0320
-16,466.4650
-9,253.6070
Diluted NI Available to Com Stockholders
-4,970.2720
-4,970.2720
-5,322.0320
-16,466.4650
-9,253.6070
Basic EPS
-0.02
-0.02
-0.03
-0.10
-0.06
Diluted EPS
-0.02
-0.02
-0.03
-0.10
-0.06
Basic Average Shares
237,383.4550
237,383.4550
187,682.0170
169,646.8340
147,037.6950
Diluted Average Shares
237,383.4550
237,383.4550
187,682.0170
169,646.8340
147,037.6950
Total Expenses
4,285.9540
4,285.9540
7,050.6180
5,879.0480
7,268.9230
Net Income from Continuing & Discontinued Operation
-4,970.2720
-4,970.2720
-5,322.0320
-16,466.4650
-9,253.6070
Normalized Income
-4,035.4790
-4,035.4790
-5,322.0320
-5,661.3184
-7,260.6379
Interest Expense
238.8120
238.8120
374.5670
184.6700
40.0830
Net Interest Income
-238.8120
-238.8120
-374.5670
-184.6700
-40.0830
EBIT
-4,731.4600
-4,731.4600
-4,947.4650
-16,352.3330
-9,251.2720
EBITDA
-4,516.3920
-4,516.3920
-4,738.6680
-16,151.6880
-9,079.1820
Reconciled Cost of Revenue
--
--
--
--
913.6470
Reconciled Depreciation
215.0680
215.0680
208.7970
200.6450
172.0900
Net Income from Continuing Operation Net Minority Interest
-4,970.2720
-4,970.2720
-5,322.0320
-16,466.4650
-9,253.6070
Total Unusual Items Excluding Goodwill
-934.7930
-934.7930
--
-10,851.4330
-2,001.0990
Total Unusual Items
-934.7930
-934.7930
--
-10,851.4330
-2,001.0990
Normalized EBITDA
-3,581.5990
-3,581.5990
-4,738.6680
-5,300.2550
-7,078.0830
Tax Rate for Calcs
--
--
--
0
0
Tax Effect of Unusual Items
--
--
--
-46.2864
-8.1299
12/31/2021 - 6/24/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

XBRA.CN Xebra Brands Ltd.
0.0800
0.00%
 
OPTI.CN Optimi Health Corp.
0.1850
+2.78%
 
TRIP.CN Red Light Holland Corp.
0.0350
0.00%
 
RVVTF Revive Therapeutics Ltd.
0.0230
+2.68%
 
SDZNY Sandoz Group AG
42.40
+0.07%
 
OGI.TO Organigram Global Inc.
1.6000
+0.63%
 
TRUL.CN Trulieve Cannabis Corp.
6.19
-4.48%
 
ESPR Esperion Therapeutics, Inc.
0.9200
+4.39%
 
TLRY.TO Tilray Brands, Inc.
0.6900
+1.47%
 
TLRY Tilray Brands, Inc.
0.4871
-1.06%